WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , Scientific Journal Impact Factor (SJIF) , IFSIJ Measure of Journal Quality , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , Research Publication Rating and Indexing , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

ISSN 2457-0400

Impact Factor  :  6.711

WJAHR Citation

  All Since 2020
 Citation  105  60
 h-index  4  4
 i10-index  3  2

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased to 6.711 for Year 2024.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR January 2026 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

  • WJAHR: JANUARY ISSUE PUBLISHED

    JANUARY 2026 Issue has been successfully launched on JANUARY 2026.

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

SYSTEMIC ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA: A CASE REPORT OF AN ASYMPTOMATIC PATIENT FROM SYRIA

Lujain Hamdan*, Souliman Diab, Zuheir Al-Shehabi and Michael Georgeos

ABSTRACT

Anaplastic large cell lymphomas (ALCLs) are uncommon malignancies; they include a group of CD30-positive Non-Hodgkin T-cell lymphomas that share similar morphologic and immunophenotypic features. The World Health Organization identifies 3 entities: primary cutaneous ALCL, anaplastic lymphoma kinase (ALK)-positive ALCL, and ALK-negative ALCL. ALK-negative ALCL is known for its aggressive behaviour and poor prognosis. It usually affects males at a median age of 55-60 years old. The majority of patients are presented with B symptoms and stage III–IV of the disease. Medical literature has reported very few cases of systemic ALK-negative ALCL. Here we demonstrate a unique case of a 47-year-old male, with no systemic symptoms, diagnosed with a stage IV, CD30+, ALK-negative ALCL presented with several tender, enlarged, inguinal lymph nodes and extranodal involvement in the skin, lung, liver and the bone marrow.

[Full Text Article] [Download Certificate]